• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

    • Radiology
      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Respiratory Syncytial Virus Market Size is Projected to Reach US$ 4,202.6 Million by 2027| Astute Analytica

May 17th, 2022 Astute Analytica Releases

The global respiratory syncytial virus market is expected to register a CAGR of 14.9% growth and revenue is expected to increase from US$ 1,823.3 Million in 2021 to reach 4,202.6 Million by 2030.

Get a Free Sample Copy of this Report@ https://www.astuteanalytica.com/request-sample/respiratory-syncytial-virus-market

Respiratory Syncytial Virus (RSV) is the major reason behind the number of respiratory disorders, including bronchiolitis, bronchitis, or pneumonia. RSV symptoms are pretty much similar to a typical cold in healthy persons. However, it can progress to a severe condition in individuals with a compromised immune system or the elderly. Moreover, cough, sputum production, wheezing, and fever were some of the most prevalent clinical symptoms.

Factor such as increased disease prevalence and the advent of targeted therapies drives the growth in the global respiratory syncytial virus market over the forecast period. The most common targeted therapy is the use of antiviral drugs specifically to inhibit one or more steps of virus replication. Moreover, rising government funding for treatment and proactive government initiatives creates a lucrative growth opportunity in the market. However, the high cost of technology and inaccessibility of diagnostic facilities inhibits the market growth. The high cost is associated due to the application of advanced technology in the medical field and the complexity of developing and manufacturing biological products.

On the basis of drug type, the synagis segment held the largest share in the respiratory syncytial virus market in 2021 as its FDA-approved prescription contains virus-fighting antibodies and aids in the prevention of serious respiratory tract infections. Whereas virazole is expected to grow at the highest CAGR during the forecast period due to its characteristic of having a broad spectrum of antiviral activity in vitro.

Moreover, based on dosage form, the injectable segment is estimated to hold the largest market share over the forecast period. Whereas the oral segment is anticipated to project the highest CAGR owing to its beneficial features of safety, good patient compliance, ease of ingestion, and pain avoidance.

Furthermore, by treatment type, the immune prophylaxis segment dominated the respiratory syncytial virus market in 2021. Whereas the antiviral medication segment is anticipated to grow at the highest CAGR over the forecast period as it decreases the chances of RSV hospitalization in premature babies. Also, many known pharmaceutical companies are involved in the development of drugs against RSV infection.

In addition, based on the distribution channel, the hospital segment dominated the market in 2021 due to the increased number of hospitalizations. Whereas the clinic segment is projected to grow at the highest CAGR during the forecast period. Due to the availability of drugs, online patient monitoring, and low availability of space in hospitals, there was significant growth in the clinics. Also, due to the pandemic situation, people avoid visiting hospitals.

By region, North America holds the largest market share in 2021 owing to high prevalence of RSV infection in the region. Whereas Asia Pacific is anticipated to project the highest CAGR over the forecast period. Countries like Japan and Australia have developed healthcare infrastructure and have a higher penetration of respiratory syncytial virus medicines.

Scope of Treatment

Vaccine- Currently, the focus of treatment is on vaccines intended for infants and toddlers (aged 28 days to 23 months), and pregnant women, with the intent to prevent RSV in their infants and older adults.

Monoclonal Antibodies- The focus of treatment is to use monoclonal antibodies that exert virus neutralization activity for preexposure prophylaxis of RSV disease in neonates (age 0-27 days), infants, and toddlers.

Antiviral Agents- The focus is on evaluating direct-acting antiviral agents (DAAs) for the treatment of RSV disease in infants and toddlers and in elderly people, with or without co-morbidities or immunodeficiencies predisposing them to RSV disease.

Company Profile

  • AbbVie, Inc. operates across several key therapeutic areas such as immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. They combine advanced science, expertise, and passion in order to solve the world’s most serious health issues and have a remarkable impact on people’s lives. Moreover, immunology holds the highest share in terms of business revenue segmentation.
  • Atea Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company focuses on the discovery of oral direct-acting antiviral therapies and serves all types of patients, healthcare professionals, pharmaceutical, and biotechnology industries worldwide. It is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatments.
  • Gilead Sciences, Inc., is an American biopharmaceutical company that mainly focuses on researching and developing antiviral drugs which are used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. It is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. Its product comprises HIV and influenza diseases.

Competitive Insight

The global Respiratory Syncytial Virus Market is highly competitive in nature. Some of the key players operating in the market include AstraZeneca, AbbVie, Inc., Bausch Health Companies, Inc., Pfizer, Inc., SOBI, GlaxoSmithKline, GlaxoSmithKline, Johnson & Johnson, and Pfizer among others.

Segmentation Overview

The industry trends in the Global Respiratory Syncytial Virus market are sub-divided into different categories in order to get a holistic view of the global marketplace. Following are the different segments of the Global Respiratory Syncytial Virus Market:

Drug Type

  • Ribavirin
  • Synagis
  • Virazole
  • Palivizumab
  • Riba Tab
  • Others

Dosage Form

  • Oral
  • Injectable
  • Inhaler
  • Others

Treatment Type

  • Immune prophylaxis
  • Supportive care
  • Antiviral Medications

Distribution Channel

  • Hospital pharmacies
  • Drug Stores
  • Retail pharmacies
  • Clinics

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • The UK
    • Germany
    • France
    • Italy
    • Spain
    • Poland
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • ASEAN
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of MEA
  • South America
    • Argentina
    • Brazil
    • Rest of South America

Access Full Report@ https://www.astuteanalytica.com/request-sample/respiratory-syncytial-virus-market

About Astute Analytica 

Astute Analytica is a global analytics and advisory company which has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.

Contact us:

Aamir Beg
BSI Business Park, H-15,Sector-63, Noida- 201301- India
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)
Email: sales@astuteanalytica.com 
Website: www.astuteanalytica.com
 Follow US: LinkedIn | Twitter

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email